Last quarter (Q0 0), Molecule Holdings's total revenue was $714.28K, a decrease of -5.77% from the same quarter last year. In Q0, Molecule Holdings's net income was $-786.94K. See Molecule Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Oct 22	Oct 21	Oct 20	Oct 19
Total Revenue	$ 1.78M	$ 1.97M	$ 455.26K	$ ―	$ ―
Cost of Revenue	$ 2.23M	$ 3.04M	$ 955.00K	$ ―	$ ―
Gross Profit	$ -449.70K	$ -1.07M	$ -499.74K	$ ―	$ ―
Operating Expense	$ 2.17M	$ 2.84M	$ 2.89M	$ 1.83M	$ 1.10M
Operating Income	$ -2.62M	$ -3.91M	$ -3.39M	$ -1.83M	$ -1.10M
Net Non Operating Interest Income Expense	$ -784.21K	$ -631.78K	$ 660.24K	$ 36.86K	$ -5.86K
Other Income Expense	$ 172.50K	$ 2.06K	$ -173.26K	$ -1.46M	$ ―
Pretax Income	$ -3.57M	$ -4.54M	$ -4.23M	$ -3.33M	$ -1.09M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -3.57M	$ -4.54M	$ -4.23M	$ -3.33M	$ -1.09M
Basic EPS	$ -0.04	$ -0.05	$ -0.05	$ -0.04	$ -0.02
Diluted EPS	$ -0.04	$ -0.05	$ -0.05	$ -0.04	$ -0.02
Basic Average Shares	$ 391.12M	$ 97.11M	$ 91.86M	$ 75.71M	$ 46.56M
Diluted Average Shares	$ 391.12M	$ 97.11M	$ 91.86M	$ 75.71M	$ 46.56M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 4.40M	$ 5.88M	$ -3.85M	$ -1.83M	$ -1.10M
Net Income From Continuing And Discontinued Operation	$ -3.57M	$ -4.54M	$ -4.23M	$ -3.33M	$ -1.09M
Normalized Income	$ -2.62M	$ -3.34M	$ -3.00M	$ -2.45M	$ -802.07K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -2.78M	$ -3.91M	$ -3.57M	$ -3.28M	$ -1.08M
EBITDA	$ -2.13M	$ -3.26M	$ -3.00M	$ -3.23M	$ -1.05M

Currency in USD

Molecule Holdings Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing